Dr Reddys Laboratories (RDY) Price to Earnings (2009 - 2026)

Dr Reddys Laboratories has reported Price to Earnings for 18 years, with the latest figure at 258.17 in Q2 2026.

• On a quarterly basis, Price to Earnings rose 241.02% year-over-year to 258.17 in Q2 2026; TTM through Jun 2026 was 958.56, a 3086.52% increase from a year earlier, with the FY2026 full-year figure at 23.81, up 51.65% from the prior year.
• Price to Earnings was 258.17 for Q2 2026 at Dr Reddys Laboratories, down from 2890.0 in the prior quarter.
• The five-year high for Price to Earnings was 2890.0 in Q1 2026, with the low at 166.76 in Q1 2025.
• Average Price to Earnings over 5 years is 257.17, with a median of 72.21 recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Price to Earnings sank 314.5% in 2025, then surged 1832.98% in 2026.
• Over 5 years, Price to Earnings stood at 73.61 in 2022, then slipped by 4.95% to 69.97 in 2023, then increased by 12.45% to 78.68 in 2024, then slumped by 173.35% to 57.71 in 2025, then surged by 547.33% to 258.17 in 2026.
• The last three Price to Earnings figures came in at 258.17 (Q2 2026), 2890.0 (Q1 2026), and 57.71 (Q4 2025), per Business Quant data.